In conclusion, our results highlighted that CFH overexpression in lung cancer is due to the demethylation of the STAT4 regulatory region, resulting in its over expression, which may be activated by the JAK/STAT pathway negatively controlled by SOCS-1 proteins (Figure 6). Here, STAT4 is linked to lung cancer.